Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

24 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Antitumor activity of novel POLA1-HDAC11 dual inhibitors.
Dallavalle S, Musso L, Cincinelli R, Darwiche N, Gervasoni S, Vistoli G, Guglielmi MB, La Porta I, Pizzulo M, Modica E, Prosperi F, Signorino G, Colelli F, Cardile F, Fucci A, D'Andrea EL, Riccio A, Pisano C. Dallavalle S, et al. Among authors: signorino g. Eur J Med Chem. 2022 Jan 15;228:113971. doi: 10.1016/j.ejmech.2021.113971. Epub 2021 Nov 3. Eur J Med Chem. 2022. PMID: 34772529
Novel adamantyl retinoid-related molecules with POLA1 inhibitory activity.
Cincinelli R, Musso L, Guglielmi MB, La Porta I, Fucci A, Luca D'Andrea E, Cardile F, Colelli F, Signorino G, Darwiche N, Gervasoni S, Vistoli G, Pisano C, Dallavalle S. Cincinelli R, et al. Among authors: signorino g. Bioorg Chem. 2020 Nov;104:104253. doi: 10.1016/j.bioorg.2020.104253. Epub 2020 Sep 2. Bioorg Chem. 2020. PMID: 32920362
Hybrid topoisomerase I and HDAC inhibitors as dual action anticancer agents.
Cincinelli R, Musso L, Artali R, Guglielmi MB, La Porta I, Melito C, Colelli F, Cardile F, Signorino G, Fucci A, Frusciante M, Pisano C, Dallavalle S. Cincinelli R, et al. Among authors: signorino g. PLoS One. 2018 Oct 9;13(10):e0205018. doi: 10.1371/journal.pone.0205018. eCollection 2018. PLoS One. 2018. PMID: 30300374 Free PMC article.
24 results